Bioxodes

Gosselies, Belgium · Founded 2010 · Privately Held (backing)

Operator of a clinical-stage biopharmaceutical company intended to prevent and treat thrombotic and inflammatory diseases. Bioxodes is based in Gosselies, Belgium and was founded in 2010. Its last reported valuation was $116 million in Feb 2025. It has raised $39.1 million.

Last reported valuation

$115.5M

Oct 2026

Priced at

—

Total raised

$39.1M

Last round

—

How much has Bioxodes raised?

$39.1Macross 0 recorded rounds

Free account

More of Bioxodes with a free account

·The complete investor list: 12 names
·Watch Bioxodes: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Bioxodes investors

12 investors are on record for Bioxodes, including European Regional Development Fund (Brandenburg), SambrInvest, Société Fédérale de Participations et d'Investissement and Federal Holding and Investment Company (Brussels).

For fundraisers

Raising for a company like Bioxodes?

12 investors have backed Bioxodes.

See all 12 investors →

Frequently asked about Bioxodes

How much has Bioxodes raised?: Bioxodes has raised $39.1M in total across 0 recorded funding rounds.